Updates

In 2019, ROW launched the Amanda Award to honor the memory of Amanda Brooke de los Santos, who passed away from seizures at a young age. Each year, ROW awards a grant to an individual or organization...

While the epilepsy treatment gap is a complex problem, simple solutions can have a life-changing impact. For example, our partner, Guiding Light Orphans (GLO) in Uganda. Its “Village Health Team” goes...

On September 1, the International Bureau for Epilepsy (IBE) announced their 2021 IBE Golden Light Awards, which coincided with the 34th International Epilepsy Congress. This award recognizes young people who have epilepsy...

Ranked 182nd out of 189 countries on the Human Development Index, Sierra Leone is a priority country for ROW Foundation. Since 2018, we’ve provided ongoing grants of Roweepra® (levetiracetam) to...

According to the World Health Organization, stigma and discrimination around epilepsy are more difficult to overcome than the seizures themselves. In low-income countries, human rights violations are widespread and...

The two legally distinct entities of OWP Pharmaceuticals and ROW Foundation form a social enterprise to improve the lives of people with epilepsy and associated psychiatric disorders in under-resourced areas of the world...

COVID-19 continues to impact daily life in a multitude of ways across the globe. Our hearts go out to the people of India, where the current surge has reached new highs and re-shaped our initiative to improve epilepsy care in rural areas...

Uganda is a country where ROW wants to move the needle on reducing untreated epilepsy. This past month, we expanded our partnerships there to include Epilepsy Awareness Uganda (EAU). EAU was founded by...

There have been some exciting developments in our partnership in India, a country that has 1/6th of the people with epilepsy globally and treatment gaps as high as 90% in rural areas. Epilepsy is so stigmatized in parts of the country that...